NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637139. A total of 13 filers reported holding NABRIVA THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1 | – | 28 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 26,682 | $46,610 | 0.03% |
Frazier Life Sciences Management, L.P. | 17,025 | $29,741 | 0.00% |
ROYAL BANK OF CANADA | 20 | $0 | 0.00% |
UBS Group AG | 1,315 | $2,297 | 0.00% |
OSAIC HOLDINGS, INC. | 2,008 | $3,214 | 0.00% |
FMR LLC | 400 | $692 | 0.00% |
BANK OF AMERICA CORP /DE/ | 84 | $147 | 0.00% |
WELLS FARGO & COMPANY/MN | 40 | $70 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 4,108 | $7,176 | 0.00% |